Pharmaceutical manufacturers urged the U.S. Court of Appeals for the Third Circuit on Wednesday to declare unconstitutional a federal program meant to lower prescription costs, one of several ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback